Novavax, Inc.
NVAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$202,379 | $106,508 | $518,646 | -$81,030 |
| Dep. & Amort. | $6,585 | $7,563 | $8,340 | $12,517 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,214 | $10,285 | $10,448 |
| Change in WC | $165,927 | -$240,331 | -$739,599 | -$48,646 |
| Other Non-Cash | $137,671 | -$10,416 | $16,826 | -$66,452 |
| Operating Cash Flow | $107,804 | -$127,462 | -$185,502 | -$173,163 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,017 | -$247 | -$1,595 | -$2,252 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$235,012 | $0 | -$114,724 | -$384,328 |
| Inv. Sales/Matur. | $100,500 | $111,625 | $43,000 | $337,944 |
| Other Inv. Act. | $0 | -$280 | $0 | $192,643 |
| Investing Cash Flow | -$136,529 | $111,098 | -$73,319 | $144,007 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $41,622 | -$612 | -$2,201 | -$2,756 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $820 | -$428 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$4,860 | -$666 |
| Financing Cash Flow | $42,442 | -$1,040 | -$7,061 | -$3,422 |
| Forex Effect | $629 | $7,906 | -$930 | -$10,717 |
| Net Chg. in Cash | $14,346 | -$9,498 | -$266,812 | -$43,295 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $264,493 | $278,480 | $545,292 | $588,587 |
| End Cash | $278,839 | $268,982 | $278,480 | $545,292 |
| Free Cash Flow | $105,787 | -$127,709 | -$187,097 | -$175,415 |